Neuralstem, Inc. is focused on developing and commercializing of treatments for central nervous system disease based on transplanting human neural stem cells and small molecule drugs. The Company has developed and maintain a portfolio of patents and patent applications that form the base of its research and development efforts in the areas of neural stem cell research, small molecule research, and related technologies.
04/10/11Neuralstem shares jump over 13% on new stem cell patent
16/12/10Neuralstem Receives FDA Approval to Start Phase Ia Trial for Depression Drug
14/09/10Study Shows Neuralstem’s Stem Cells May Have Application To Treating Stroke
Recent Sector News
U.S. stocks dropped dramatically Thursday, with the Dow settling down more than 300 points for its biggest decline in six months as investors were still digesting mixed messages from the Fed's latest policy statement, riddled with uncertainty over raising rates and nervous ahead of the monthly jobs report tomorrow.
Tweed Marijuana's (CVE:TWD) shares rallied over 5 percent on Thursday after the company said it will be releasing up to 18 additional marijuana varieties beginning next week, for sale in August and September.
Kane Biotech's (CVE:KNE) shares added more than 18 percent after the company said it has obtained approval from Health Canada for its dermatological products DispersinB skin cream and shampoo for human use.
U.S. stocks fell Monday amid heightened global tensions, as investors digested news of more deaths from the Israeli-Palestine conflict and as Europe threatened more sanctions against Russia after the downing of the Malaysia Airlines jet last week.
Bioniche Life Sciences (TSE:BNC) saw its share price more than double Friday after the company said it is planning to file for U.S. marketing approval of its treatment for patients with a type of bladder cancer.
Pacific Therapeutics (CSE:PT) (OTC:PCFTF) has teamed up with Vodis Innovative Pharmaceuticals, with the two parties to work together on the development of therapies based on extracts from cannabis plants.
Investors interested in Neuralstem recently viewed
- Pivotal Therapeutics (OTCQX:PVTTF, CNSX: PVO) Extracting the Science and Formulating Superior Therapeutics
- Amphion Innovations (LON: AMP) Amphion builds shareholder value in the medical and technology sectors
- Epistem Holdings Plc (AIM: EHP) Biotechnology company applying its expertise in epithelial stem cells
- Medical Australia Limited (ASX: MLA) Medical devices developed, manufactured and distributed in Australia.
- ImmuPharma PLC (AIM: IMM) Drug Discovery & Development to Treat Lupus, Cancer & MRSA